mesowatch
divider
John Edwards

Reading Time: 6 mins

Published On: September 22, 2024

Page Features:14 cited research

John Edwards - author

John Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

Jump to a topic


Related Pages

divider

warning icon

Find out if you Qualify for a Asbestos Cancer Lawsuit

warning icon

Find out if you Qualify for a Asbestos Cancer Lawsuit

Crocidolite Asbestos: The Blue Asbestos Menace

Crocidolite Asbestos: The Blue Asbestos Menace

Related Pages

divider
John Edwards

Reading Time: 6 mins

Published On: September 22, 2024

Page Features:14 cited research

John Edwards - author

John Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

Jump to a topic


14 References

divider

VIEW 0 MORE REFERENCES

Related Content

divider
Johnson & Johnson Faces Critical Legal Test in Connecticut
Johnson & Johnson Faces Critical Legal Test in Connecticut

Matthew Davis
5 mins read - September 23, 2024

The first trial in Connecticut involving Johnson & Johnson’s cosmetic talc products has begun, marking a significant legal challenge for the company. The case...

Settlements

FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma

Amna Anees
2 mins read - September 23, 2024

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda) in combination with chemotherapy as a first-line treatment for patients with unresectable...

Treatment

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds
Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

Jared Reagan
8 mins read - September 23, 2024

Asbestos was once seen as a wonder material because it could resist heat so well. But it’s left behind a deadly problem. Even though many countries have banned it including...

Awareness

Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.DMCA.com Protection Status